Seven of the 8 urine biomarkers were increased in subjects with bladder cancer relative to those without bladder cancer.
urine biomarkers [fluorescence in situ hybridisation (FISH), ImmunoCyt, NMP22] and cytology for the detection and follow-up of bladder cancer.
.
